These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31098655)

  • 1. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
    Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
    Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of mitragynine (kratom) in rats.
    Harun N; Hassan Z; Navaratnam V; Mansor SM; Shoaib M
    Psychopharmacology (Berl); 2015 Jul; 232(13):2227-38. PubMed ID: 25616583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive Effects of
    Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
    J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
    Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
    J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
    Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
    Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
    Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
    Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
    Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
    Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats.
    Carpenter JM; Criddle CA; Craig HK; Ali Z; Zhang Z; Khan IA; Sufka KJ
    Fitoterapia; 2016 Mar; 109():87-90. PubMed ID: 26688378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system.
    Shamima AR; Fakurazi S; Hidayat MT; Hairuszah I; Moklas MAM; Arulselvan P
    Int J Mol Sci; 2012; 13(9):11427-11442. PubMed ID: 23109863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
    Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
    Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats.
    Wilkerson JL; Felix JS; Restrepo LF; Ansari MI; Coop A; McMahon LR
    J Pharmacol Exp Ther; 2019 Sep; 370(3):380-389. PubMed ID: 31235534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors.
    Matsumoto K; Mizowaki M; Suchitra T; Takayama H; Sakai S; Aimi N; Watanabe H
    Life Sci; 1996; 59(14):1149-55. PubMed ID: 8831802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa.
    Matsumoto K; Horie S; Takayama H; Ishikawa H; Aimi N; Ponglux D; Murayama T; Watanabe K
    Life Sci; 2005 Nov; 78(1):2-7. PubMed ID: 16169018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist.
    Mada S; Gerak LR; Soyer A; Maguire DR; Hu Z; Minervini V; Cunningham CW; France CP
    Psychopharmacology (Berl); 2020 Dec; 237(12):3591-3602. PubMed ID: 32820390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa.
    Matsumoto K; Horie S; Ishikawa H; Takayama H; Aimi N; Ponglux D; Watanabe K
    Life Sci; 2004 Mar; 74(17):2143-55. PubMed ID: 14969718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
    Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
    J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitragynine, a primary constituent of kratom reinstates morphine-seeking behaviour in rats.
    Japarin RA; Harun N; Hassan Z; Shoaib M
    Behav Pharmacol; 2023 Apr; 34(2-3):123-130. PubMed ID: 36752325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism.
    Foss JD; Nayak SU; Tallarida CS; Farkas DJ; Ward SJ; Rawls SM
    Drug Alcohol Depend; 2020 Apr; 209():107946. PubMed ID: 32145665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.